Your account is not claimed yet. You can sign up with ORCID to claim your account.

Mario E Lacouture (M E Lacouture, M Lacouture, Mario Lacouture)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 15

Top Venues

The oncologist

Journal of the European Academy of Dermatology and Venereology : JEADV

Breast cancer research and treatment

The Journal of urology

Weill Cornell Medical College

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Weill Cornell Medical College

United States

Associate Professor :: Dermatology

Publications

Azael Freites Martinez, Zoi Apalla, Davide Fattore, Monika Fida, Alexander S Bang, Janellen Smith, Shahab Babakoohi, Mario E Lacouture, Vincent Sibaud
Supportive oncodermatology practices in Europe and the USA. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Lukas Kraehenbuehl, D Kang, A S Bang, K F Ketosugbo, J Hay, Sujata Patil, S Goldfarb, J Cho, Mario E Lacouture
Validation and Responsiveness of the English version of the Chemotherapy-Induced Alopecia Distress Scale (CADS) in Breast Cancer Patients. medRxiv : the preprint server for health sciences (2023)
Mario E Lacouture, Anisha B Patel, Jonathan E Rosenberg, Peter H O'Donnell
Management of Dermatologic Events Associated With the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin. The oncologist 27 (3) (2022)
Alexander Pan, Rachel E Reingold, Jimmy L Zhao, Andrea Moy, Lukas Kraehenbuehl, George Dranitsaris, Sean M McBride, Howard I Scher, Marisa A Kollmeier, Han Xiao, Dana E Rathkopf, Mario E Lacouture
Dermatological Adverse Events in Prostate Cancer Patients Treated with the Androgen Receptor Inhibitor Apalutamide. The Journal of urology 207 (5) (2022)
Alexander Sydat Bang, J Monnier, U Harris, J Garfinkel, G Rubinstein, N Iftimia, M Pulitzer, M Murray, Mario E Lacouture, Manu Jain
Non-invasive, in vivo, characterization of cutaneous metastases using a novel multimodal RCM-OCT imaging device: a case-series. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (11) (2022)
Mario E Lacouture, Anisha B Patel, Jonathan E Rosenberg, Peter H O'Donnell
In Reply. The oncologist 27 (10) (2022)
Zoi Apalla, Vasiliki A Nikolaou, Davide Fattore, Gabriella Fabbrocini, A Freites-Martinez, Pietro Sollena, Mario E Lacouture, L Kraehenbuehl, A Stratigos, Ketty Peris, Elisabeth Lazaridou, Bertrand Richert, E Vigarios, J Riganti, B Baroudjian, A Filoni, R Dodiuk-Gad, C Lebbé, V Sibaud
European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statement. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (3) (2021)
Mario E Lacouture, Hedy Dion, Shobha Ravipaty, Joaquin J Jimenez, Khampaseuth Thapa, Eric M Grund, Ely Benaim, Nikunj Tanna, Shen Luan, Nathaniel DiTommaso, Niven R Narain, Rangaprasad Sarangarajan, Elder Granger, Brian Berman, Shari B Goldfarb
A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia. Breast cancer research and treatment 186 (1) (2020)
Cesar A Virgen, Christopher A Barker, Mario E Lacouture
The microbial flora of clinically infected cutaneous metastases: a retrospective study. Clinical and experimental dermatology 45 (6) (2020)
Mario E Lacouture, Vincent Sibaud, Milan J Anadkat, Benjamin Kaffenberger, Jonathan Leventhal, Kathleen Guindon, Ghassan Abou-Alfa
Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines. The oncologist 26 (2) (2020)
Bruno Vincenzi, Mike Trower, Ajay Duggal, Pamela Guglielmini, Peter Harris, David Jackson, Mario E Lacouture, Emiliangelo Ratti, Giuseppe Tonini, Andrew Wood
Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial. BMJ open 10 (2) (2020)
Diana G Wang, Dulce M Barrios, Victoria S Blinder, Jacqueline F Bromberg, Pamela R Drullinsky, Samuel A Funt, Komal L Jhaveri, Diana E Lake, Tomas Lyons, Shanu Modi, Pedram Razavi, Michelle Sidel, Tiffany A Traina, Linda T Vahdat, Mario E Lacouture
Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer. Breast cancer research and treatment 183 (1) (2020)
D M Barrios, G S Phillips, A Freites-Martinez, M Hsu, K Ciccolini, A Skripnik Lucas, M A Marchetti, A M Rossi, E H Lee, L Deng, A Markova, P L Myskowski, Mario E Lacouture
Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (6) (2020)
Karmela Kim Chan, Cynthia Magro, Alexander N Shoushtari, Charles M Rudin, Veronica M Rotemberg, Anthony Rossi, Cecilia Lezcano, John A Carrino, David Fernandez, Michael A Postow, Arlyn Apollo, Mario E Lacouture, Anne R Bass
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature. The oncologist (2019)
Karmela Kim Chan, Cynthia Magro, Alexander N Shoushtari, Charles M Rudin, Veronica M Rotemberg, Anthony Rossi, Cecilia Lezcano, John A Carrino, David Fernandez, Michael A Postow, Arlyn Apollo, Mario E Lacouture, Anne R Bass
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature. The oncologist 25 (2) (2019)

Mario E Lacouture.css-eqlu8i{font-size:small;padding-left:4px;} (M E Lacouture, M Lacouture, Mario Lacouture)

Publication Activity (10 Years)

Top Topics

Top Venues

Mario E Lacouture (M E Lacouture, M Lacouture, Mario Lacouture)